DEVYSER DIAGNOSTICS AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 102.5 SEK | -2.38% |
|
0.00% | +30.41% |
| 04-25 | Devyser Receives IVDR Approval for Post-Transplant Monitoring Software | CI |
| 03-11 | Devyser Diagnostics AB Achieves Breakthrough in the US with Cystic Fibrosis NGS Test | CI |
Chart calendar Devyser Diagnostics AB
881bbed91db72b3d66bd82bd60cec8.XfFkO5AxucApTq9MYZCcKAbNpBHsosU00lj_4uVNMw0.DMUAWclc1a9rJMc_OMHtSVf-62G-2JRbuyq4q68eY3snvQNp8l74px806g~44a3a1fe9b8b7840d3d4f2bbce06e57c
Upcoming events on Devyser Diagnostics AB
Past events on Devyser Diagnostics AB
| 20/03/2024 09:10 | Redeye Theme: Commercialization in Life Science |
| 20/02/2024 08:00 | Q4 2023 Earnings Call |
| 20/02/2024 06:30 | Q4 2023 Earnings Release |
| 09/11/2023 08:00 | Q3 2023 Earnings Call |
| 09/11/2023 06:30 | Q3 2023 Earnings Release |
| 23/08/2023 08:00 | Q2 2023 Earnings Call |
| 23/08/2023 07:07 | Q2 2023 Earnings Release |
| 09/05/2023 | Annual General Meeting |
| 09/05/2023 08:00 | Q1 2023 Earnings Call |
| 09/05/2023 07:00 | Q1 2023 Earnings Release |
| 30/03/2023 05:00 | Redeye Future of Healthcare Event |
| 21/02/2023 08:00 | FY 2022 Earnings Call |
| 21/02/2023 06:43 | FY 2022 Earnings Release |
| 10/11/2022 07:30 | Q3 2022 Earnings Call |
| 10/11/2022 06:44 | Q3 2022 Earnings Release |
| 24/08/2022 08:00 | Interim 2022 Earnings Call |
| 24/08/2022 07:21 | Interim 2022 Earnings Release |
| 11/05/2022 08:00 | Q1 2022 Earnings Call |
| 11/05/2022 07:23 | Q1 2022 Earnings Release |
| 10/05/2022 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 | 93,5 91,9 1.74% | 127 127 -0% | 169 170 -0.26% | 250 |
|
EBITDA Million SEK | Released Forecast Spread | 0,00 | -15,2 -5,41 -180.96% | -43,4 -31,1 -39.37% | -45,8 -40,7 -12.41% | 10,4 |
|
EBIT Million SEK | Released Forecast Spread | 0,00 | -21,2 -10,0 -111.79% | -52,0 -37,8 -37.75% | -58,9 -49,1 -19.93% | -1,32 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 0,00 | -21,9 -9,71 -125.54% | -52,7 -39,4 -33.84% | -54,4 -47,2 -15.35% | -0,42 |
|
Net income Million SEK | Released Forecast Spread | -10,9 | -20,7 -9,71 -113.18% | -46,0 -39,9 -15.22% | -53,6 -43,2 -23.97% | -3,36 |
|
EPS DKK | Released Forecast Spread | 0,00 | -1,30 -0,87 -49.26% | -1,95 -1,70 -14.61% | -2,20 -1,74 -26.55% | -0,15 |
| Announcement Date | 11/05/21 | 24/02/22 | 21/02/23 | 20/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 24,5 23,0 6.52% | 30,4 30,1 1% | 30,9 32,0 -3.44% | 31,2 33,2 -6.02% | 34,2 34,1 0.29% | 39,5 39,1 1.15% | 37,7 42,6 -11.4% | 46,7 41,3 13.21% | 45,4 50,2 -9.56% | 49,6 | 53,2 | 58,5 | 62,5 |
|
EBITDA Million SEK | Released Forecast Spread | -16,3 -10,1 -61.39% | -11,1 -16,1 31.06% | -4,10 -7,60 46.05% | -14,2 -3,60 -294.44% | |||||||||
|
EBIT Million SEK | Released Forecast Spread | -13,9 -5,00 -178% | -5,20 -5,10 -1.96% | -12,6 -5,60 -125% | -8,20 -10,9 24.77% | -25,9 -8,90 -191.01% | -19,1 -12,9 -48.06% | -13,5 -101 86.61% | -7,80 -12,9 39.3% | -18,5 -6,10 -203.28% | -9,70 | -6,90 | -3,20 | -0,50 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -19,3 -12,3 -56.91% | -13,8 -18,4 25% | -5,20 -10,3 49.51% | -16,2 -9,30 -74.19% | |||||||||
|
Net income Million SEK | Released Forecast Spread | -19,9 -12,3 -61.79% | -14,6 -18,4 20.65% | -6,00 -10,6 43.4% | -13,1 -9,50 -37.89% | |||||||||
|
EPS DKK | Released Forecast Spread | -0,83 -0,49 -67.87% | -0,57 -0,76 25.75% | -0,24 -0,41 42.14% | -0,53 -0,37 -43.62% | |||||||||
| Announcement Date | 24/02/22 | 11/05/22 | 24/08/22 | 10/11/22 | 21/02/23 | 09/05/23 | 23/08/23 | 09/11/23 | 20/02/24 | - | - | - | - |
| Today 21:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 11:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 11:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 12:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Devyser Diagnostics AB
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DVYSR Stock
- Calendar Devyser Diagnostics AB
